Tao Lu

3.9k total citations
176 papers, 3.3k citations indexed

About

Tao Lu is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Tao Lu has authored 176 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Organic Chemistry, 85 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Tao Lu's work include Catalytic C–H Functionalization Methods (40 papers), N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (25 papers) and Catalytic Cross-Coupling Reactions (24 papers). Tao Lu is often cited by papers focused on Catalytic C–H Functionalization Methods (40 papers), N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (25 papers) and Catalytic Cross-Coupling Reactions (24 papers). Tao Lu collaborates with scholars based in China, United States and Singapore. Tao Lu's co-authors include Ding Du, Weifang Tang, Yadong Chen, Qingfa Zhou, Yanmin Zhang, Xiaowei Dou, Chao Fang, Haichun Liu, Kewen Sun and Na Liu and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Tao Lu

174 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Lu China 33 2.1k 1.3k 330 274 239 176 3.3k
Hai‐Bing Zhou China 31 1.4k 0.7× 1.1k 0.9× 352 1.1× 191 0.7× 294 1.2× 128 2.8k
Surya K. De United States 33 2.0k 1.0× 1.3k 1.0× 312 0.9× 130 0.5× 236 1.0× 121 3.2k
Luoting Yu China 29 1.1k 0.5× 1.6k 1.2× 476 1.4× 126 0.5× 144 0.6× 141 2.9k
Allan M. Jordan United Kingdom 27 2.7k 1.3× 2.5k 2.0× 515 1.6× 347 1.3× 500 2.1× 61 4.9k
Joachim Rudolph United States 27 1.1k 0.5× 1.6k 1.3× 515 1.6× 246 0.9× 207 0.9× 61 3.0k
Joel C. Barrish United States 29 1.4k 0.6× 882 0.7× 301 0.9× 134 0.5× 173 0.7× 104 2.3k
Kyung Ho Yoo South Korea 28 1.3k 0.6× 825 0.7× 238 0.7× 163 0.6× 91 0.4× 107 2.0k
Zhaopeng Liu China 25 869 0.4× 849 0.7× 241 0.7× 102 0.4× 154 0.6× 127 2.1k
Shyam Krishnan United States 15 1.2k 0.6× 838 0.7× 209 0.6× 147 0.5× 112 0.5× 15 1.7k
Runtao Li China 29 2.1k 1.0× 1.0k 0.8× 251 0.8× 102 0.4× 271 1.1× 166 2.9k

Countries citing papers authored by Tao Lu

Since Specialization
Citations

This map shows the geographic impact of Tao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Lu more than expected).

Fields of papers citing papers by Tao Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Lu. The network helps show where Tao Lu may publish in the future.

Co-authorship network of co-authors of Tao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Lu. A scholar is included among the top collaborators of Tao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Lu. Tao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhijie, Xun Lu, Fei Huang, et al.. (2024). Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations. European Journal of Medicinal Chemistry. 268. 116237–116237. 4 indexed citations
2.
Yang, Na, Bo Kong, Fei Huang, et al.. (2023). Recent advances in targeted protein degraders as potential therapeutic agents. Molecular Diversity. 28(1). 309–333. 23 indexed citations
3.
Zhang, Ruyue, et al.. (2023). Discovery of Thieno[3,2-d]pyrimidine derivatives as potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) kinase. European Journal of Medicinal Chemistry. 255. 115370–115370. 13 indexed citations
4.
Zhang, Tongtong, et al.. (2023). Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities. Bioorganic & Medicinal Chemistry Letters. 81. 129148–129148. 12 indexed citations
5.
Wang, Zhijie, Donglin Wu, Xiaofei Zhao, et al.. (2023). Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy. European Journal of Medicinal Chemistry. 260. 115759–115759. 12 indexed citations
6.
Zhi, Yanle, Hongmei Li, Qiaomei Jin, et al.. (2023). Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor. European Journal of Medicinal Chemistry. 256. 115448–115448. 5 indexed citations
7.
Lu, Tao, et al.. (2023). Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors. Bioorganic Chemistry. 136. 106535–106535. 8 indexed citations
8.
Cui, Hao, Yang Kang, Yichao Wu, et al.. (2022). Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer. European Journal of Medicinal Chemistry. 238. 114484–114484. 9 indexed citations
9.
Cui, Hao, Qianqian Hong, Ran Wei, et al.. (2021). Design and synthesis of HDAC inhibitors to enhance the therapeutic effect of diffuse large B-cell lymphoma by improving metabolic stability and pharmacokinetic characteristics. European Journal of Medicinal Chemistry. 229. 114049–114049. 23 indexed citations
10.
Huang, Chen, Jie Feng, Rui Ma, et al.. (2019). Redox-Neutral Borylation of Aryl Sulfonium Salts via C–S Activation Enabled by Light. Organic Letters. 21(23). 9688–9692. 60 indexed citations
11.
Cui, Hao, Liyuan Zhang, Xin Chen, et al.. (2019). Discovery of novel phenoxybenzamide analogues as Raf/HDAC dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(13). 1605–1608. 17 indexed citations
12.
13.
Chen, Xin, Hongmei Li, Xin Wang, et al.. (2019). Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors. European Journal of Medicinal Chemistry. 168. 110–122. 52 indexed citations
14.
Ran, Ting, Wenjuan Li, Bing‐ling Peng, et al.. (2019). Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1. Journal of Chemical Information and Modeling. 59(1). 522–534. 13 indexed citations
15.
Wang, Lu, Yanmin Zhang, Qing Zhang, et al.. (2018). Discovery of potent Pan-Raf inhibitors with increased solubility to overcome drug resistance. European Journal of Medicinal Chemistry. 163. 243–255. 9 indexed citations
16.
Xiao, Na, et al.. (2017). De Novo Computational Design for Development of a Peptide Ligand Oriented to VEGFR-3 with High Affinity and Long Circulation. Molecular Pharmaceutics. 14(7). 2236–2244. 14 indexed citations
17.
Wang, Lu, Qing Zhang, Yanmin Zhang, et al.. (2017). Rational design, synthesis, and biological evaluation of Pan-Raf inhibitors to overcome resistance. Organic & Biomolecular Chemistry. 15(16). 3455–3465. 16 indexed citations
18.
Zhang, Yanmin, Lu Wang, Qing Zhang, et al.. (2017). Potent Pan-Raf and Receptor Tyrosine Kinase Inhibitors Based on a Cyclopropyl Formamide Fragment Overcome Resistance. Journal of Chemical Information and Modeling. 57(6). 1439–1452. 7 indexed citations
19.
20.
Ran, Ting, Zhimin Zhang, Kejun Liu, et al.. (2015). Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation. Molecular BioSystems. 11(5). 1295–1304. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hai‐Bing Zhou Breakdown of academic impact, for papers by Surya K. De Breakdown of academic impact, for papers by Luoting Yu Breakdown of academic impact, for papers by Allan M. Jordan Breakdown of academic impact, for papers by Joachim Rudolph Breakdown of academic impact, for papers by Joel C. Barrish Breakdown of academic impact, for papers by Kyung Ho Yoo Breakdown of academic impact, for papers by Zhaopeng Liu Breakdown of academic impact, for papers by Shyam Krishnan Breakdown of academic impact, for papers by Runtao Li
Rankless by CCL
2026